Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors

Por Hyunjung Park, Hyerin Park, Jiyeon Baek, Hyuk Moon, Simon Weonsang Ro
Publicado em 2022-04-01

Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways

Por Hyuk Moon, Hyunjung Park, Min Jee Chae, Hye Jin Choi, Do Young Kim, Simon Weonsang Ro
Publicado em 2022-04-01